Heart and Diabetes Center North-Rhine Westfalia
hdz-nrw.deLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
33
Active
5
Phase 3
1
Total enrollment
14,079
Pipeline matrix
Showing 1 of 1 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Medical therapy | — | — | — | — | — | 1 |
Next readouts
- 2026-06-01
Top conditions
- Heart Failure8
- Atrial Fibrillation4
- Heart Transplantation2
- Obesity2
- Cardiovascular Disease2
- Congestive Heart Failure2
- Cardiac Resynchronization Therapy2
- Tricuspid Regurgitation2
Frequently asked questions about Heart and Diabetes Center North-Rhine Westfalia
- How many clinical trials does Heart and Diabetes Center North-Rhine Westfalia have on ClinicalTrials.gov?
- Heart and Diabetes Center North-Rhine Westfalia is listed as the lead sponsor on 33 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Heart and Diabetes Center North-Rhine Westfalia's trials are in Phase 3?
- 1 of Heart and Diabetes Center North-Rhine Westfalia's trials are in Phase 3, spread across 1 active drug program.
- What therapeutic areas does Heart and Diabetes Center North-Rhine Westfalia focus on?
- Heart and Diabetes Center North-Rhine Westfalia's most-studied conditions on ClinicalTrials.gov are Heart Failure, Atrial Fibrillation, Heart Transplantation, Obesity, Cardiovascular Disease.
- When are Heart and Diabetes Center North-Rhine Westfalia's next clinical trial readouts?
- Heart and Diabetes Center North-Rhine Westfalia has 1 upcoming primary-completion readout tracked here; the soonest is “Preventive Catheter Ablation for Ventricular arrhythmiaS in Patients With End-sTage Heart faiLure”, expected around 2026-06-01.